Health Canada approves new indication for Prevymis (letermovir) for prevention of cytomegalovirus (CMV) disease in high-risk adult kidney transplant recipients – Merck
Merck Inc. known as MSD outside of the United States and Canada, announced that Health Canada has approved a new indication for Prevymis (letermovir) for the prophylaxis of… read more.
